泰格医药：出售参股公司礼新医药股权

Core Viewpoint - Tiger Medical announced the sale of its stake in Lixin Pharmaceutical, agreeing to transfer 95.09% of Lixin's shares to Zhengda Pharmaceutical Investment (Beijing) Group for approximately $34.11 million [1] Group 1 - Tiger Medical directly holds a 3.41% stake in Lixin Pharmaceutical and an indirect stake of 4.58% through fund holdings [1] - After the completion of this transaction, Tiger Medical will no longer hold any shares in Lixin Pharmaceutical [1]